Autoimmune Thrombocytopenia Purpura Clinical Trials

• Treatment of Autoimmune Thrombocytopenia (AITP)
  ClinicalTrials.gov Identifier: NCT00001630 - Recruiting
  Autoimmune Disease; Autoimmune Hemolytic Anemia; Thrombocytopenia
  
• AMG 531 Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00415532 - Active, not recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenic Purpura
  
• Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
  ClinicalTrials.gov Identifier: NCT00547066 - Active, not recruiting
  Purpura, Thrombocytopenic, Idiopathic; Autoimmune Thrombocytopenic Purpura; Purpura, Thrombocytopenic, Autoimmune
  
• Retrospective & Prospective Observational Study of Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00454857 - Active, not recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenic Purpura
  
• Study of Doxil in the Treatment of Patients with Refractory Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00107913 - Recruiting
  Autoimmune Thrombocytopenic Purpura
  
• Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
  ClinicalTrials.gov Identifier: NCT00010387 - Active, not recruiting
  Anemia, Hemolytic, Autoimmune; Felty Syndrome; Purpura, Thrombocytopenic; Autoimmune Diseases
  
• An Open Label Study of AMG 531 for Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00508820 - Recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenic Purpura
  
• Safety and Efficacy Study of AMG 531 to Treat ITP in Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00515203 - Recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• AMG 531 Treatment of Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy
  ClinicalTrials.gov Identifier: NCT00102336 - Active, not recruiting
  Thrombocytopenia
  
• AMG 531 Treatment of Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy
  ClinicalTrials.gov Identifier: NCT00102323 - Active, not recruiting
  Thrombocytopenia
  
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
  ClinicalTrials.gov Identifier: NCT00006055 - Active, not recruiting
  Purpura, Schoenlein-Henoch; Graft Versus Host Disease; Anemia, Hemolytic, Autoimmune; Rheumatoid Arthritis; Churg-Strauss Syndrome; ...
  
• Open Label Extension Study of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00116688 - Recruiting
  Thrombocytopenia
  
• An Epidemiological Study of Subjects with Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
  ClinicalTrials.gov Identifier: NCT00005570 - Completed
  Purpura, Thrombocytopenic, Idiopathic; immune thrombocytopenic purpura
  
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
  ClinicalTrials.gov Identifier: NCT00110799 - Active, not recruiting
  Hepatitis C; Thrombocytopenia
  
• Open Label Extension Study of AMG 531 in Japanese Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00440037 - Recruiting
  Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo in Adults with Refractory Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00102739 - Active, not recruiting
  Purpura, Thrombocytopenic, Idiopathic
  
• A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
  ClinicalTrials.gov Identifier: NCT00194987 - Recruiting
  Alloimmune Thrombocytopenia; Fetal Alloimmune Thrombocytopenia
  
• Mechanism of Thrombocytopenia in Infants
  ClinicalTrials.gov Identifier: NCT00333333 - Recruiting
  Thrombocytopenia; Small for Gestational Age (SGA); Preeclampsia
  
• Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)
  ClinicalTrials.gov Identifier: NCT00058981 - Active, not recruiting
  Diabetes, Autoimmune
  
• Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag
  ClinicalTrials.gov Identifier: NCT00370331 - Active, not recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
  ClinicalTrials.gov Identifier: NCT00424177 - Active, not recruiting
  Chronic Idiopathic Thrombocytopenic Purpura
  
• Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy
  ClinicalTrials.gov Identifier: NCT00225875 - Terminated
  Autoimmune Thrombocytopenic Purpura
  
• Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00005652 - Active, not recruiting
  Purpura, Thrombocytopenic, Idiopathic
  
• A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
  ClinicalTrials.gov Identifier: NCT00198575 - Active, not recruiting
  Heparin-Induced Thrombocytopenia
  
• Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00372892 - Recruiting
  Purpura, Thrombocytopenic, Idiopathic
  
• Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00251277 - Recruiting
  Thrombotic Thombocytopenic Purpura; TTP; Hematology
  
• Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura
  ClinicalTrials.gov Identifier: NCT00190229 - Active, not recruiting
  Henoch-Schoenlein Purpura
  
• Heparin Induced Thrombocytopenia: Pharmacoeconomics
  ClinicalTrials.gov Identifier: NCT00456001 - Active, not recruiting
  Heparin Induced Thrombocytopenia (HIT)
  
• Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
  ClinicalTrials.gov Identifier: NCT00239733 - Recruiting
  Thrombocytopenia; Hepatitis C; HIV Infections
  
• Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults
  ClinicalTrials.gov Identifier: NCT00426270 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002665 - Active, not recruiting
  Thrombocytopenia; Leukemia, Lymphocytic; Neutropenia
  
• Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
  ClinicalTrials.gov Identifier: NCT00198588 - Recruiting
  Heparin-Induced Thrombocytopenia
  
• Pharmacokinetics and Pharmacodynamic Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00244257 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00031980 - Active, not recruiting
  Anemia; Chronic Lymphocytic Leukemia; Neutropenia; Thrombocytopenia
  
• A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
  ClinicalTrials.gov Identifier: NCT00475423 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Safety and Efficacy Study To Compare Uniplas With Cryosupernatant Plasma In Thrombotic Thrombocytopenic Purpura (TTP)
  ClinicalTrials.gov Identifier: NCT00411801 - Recruiting
  Thrombotic Thrombocytopenic Purpura (TTP)
  
• A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00504075 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura
  
• Safety Study of AMG 531 in Japanese Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00305435 - Completed
  Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• Treatment of ITP with Subcutaneously Administered Anti-D
  ClinicalTrials.gov Identifier: NCT00128882 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• A Trial to Treat Patients with ITP Who Do Not Achieve a Durable Response to Rituxan Alone
  ClinicalTrials.gov Identifier: NCT00161564 - Recruiting
  Idiopathic Thrombocytopenic Purpura (ITP)
  
• Gastrointestinal and Health-Related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate
  ClinicalTrials.gov Identifier: NCT00351377 - Recruiting
  Autoimmune Disease
  
• Transfusion Medicine/Hemostasis Clinical Research Network
  ClinicalTrials.gov Identifier: NCT00081718 - Recruiting
  Purpura, Thrombocytopenic; Blood Disease
  
• Patient Plasma Response and Outcome in Septic Shock with Thrombocytopenia Associated Multiple Organ Failure in Children
  ClinicalTrials.gov Identifier: NCT00118664 - Recruiting
  Septic Shock; Thrombocytopenia; Multiple Organ Failure
  
• Daclizumab to Treat Chronic Immune Thrombocytopenia
  ClinicalTrials.gov Identifier: NCT00049725 - Completed
  Thrombocytopenia
  
• A Dose and Schedule Finding Trial of AMG 531 for Treatment of Chemotherapy Induced Thrombocytopenia (CIT) in Subjects With Lymphoma
  ClinicalTrials.gov Identifier: NCT00283439 - Recruiting
  Chemotherapy-Induced Thrombocytopenia; Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma
  
• Angiomax in Patients with HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
  ClinicalTrials.gov Identifier: NCT00073580 - Active, not recruiting
  Thrombocytopenia; Thrombosis; Cardiac Disease; Coronary Artery Bypass Surgery
  
• Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
  ClinicalTrials.gov Identifier: NCT00341679 - Active, not recruiting
  Autoimmune/Connective Tissue Diseases; Idiopathic Inflammatory Myopathies; IIM
  
• Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
  ClinicalTrials.gov Identifier: NCT00501345 - Recruiting
  Thrombocytopenia; Myocardial Infarction
  
• Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
  ClinicalTrials.gov Identifier: NCT00331357 - Not yet recruiting
  Acute Idiopathic Thrombocytopenic Purpura
  
• Screening for Hematology Branch Protocols
  ClinicalTrials.gov Identifier: NCT00001620 - Recruiting
  Anemia; Hematologic Neoplasm; Neutropenia; Pancytopenia; Thrombocytopenia
  
• The HIT-TRAP Trial
  ClinicalTrials.gov Identifier: NCT00196417 - Active, not recruiting
  Heparin-Induced Thrombocytopenia
  
• ADAMTS13 in Thrombotic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00426686 - Recruiting
  Thrombotic Thrombocytopenic Purpura
  
• Efficacy and Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult)
  ClinicalTrials.gov Identifier: NCT00456027 - Active, not recruiting
  Latent Autoimmune Diabetes in Adult (LADA)
  
• Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00540423 - Not yet recruiting
  Chronic Idiopathic Thrombocytopenic Purpura
  
• Heparin-Induced Thrombocytopenia Score Card Study
  ClinicalTrials.gov Identifier: NCT00489437 - Not yet recruiting
  Heparin Induced Thrombocytopenia
  
• A Phase 1, Open-Label, Multiple-Dose, Dose Escalation Study of the Safety and Tolerability of Staphylococcal Protein A in Adult Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00571467 - Not yet recruiting
  Idiopathic Thrombocytopenic Purpura (ITP)
  
• Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus
  ClinicalTrials.gov Identifier: NCT00015639 - Completed
  Thrombocytopenia
  
• HSP-Glomerulonephritis Trial: MP vs CyA
  ClinicalTrials.gov Identifier: NCT00425724 - Active, not recruiting
  Purpura, Schoenlein-Henoch
  
• A Study to Determine whether Therapy with Daclizumab Will Benefit Patients with Bone Marrow Failure
  ClinicalTrials.gov Identifier: NCT00001962 - Recruiting
  Aplastic Anemia; Pure Red Cell Aplasia; Thrombocytopenic Purpura
  
• Sirolimus in Autoimmune Lymphoproliferative Syndrome: A Pilot Series
  ClinicalTrials.gov Identifier: NCT00392951 - Recruiting
  Autoimmune Lymphoproliferative Syndrome (ALPS)
  
• Cancer in Inherited Bone Marrow Failure Syndromes
  ClinicalTrials.gov Identifier: NCT00027274 - Recruiting
  Fanconi's Anemia; Anemia, Diamond-Blackfan; Dyskeratosis Congenital; Thrombocytopenia; Neutropenia
  
• Safety and efficacy of an investigational drug in the prevention of thrombocytopenia in patients receiving myelosuppressive treatment regimens requiring platelet transfusion support.
  ClinicalTrials.gov Identifier: NCT00037791 - Completed
  Neoplasms; Thrombocytopenia; Multiple Myeloma; Lymphoma, Malignant
  
• Treatment of Multiple Sclerosis with Copaxone and Albuterol
  ClinicalTrials.gov Identifier: NCT00039988 - Active, not recruiting
  Autoimmune Diseases; Multiple Sclerosis
  
• Anticoagulant Therapy with Bivalirudin in the Performance of Percutaneous Coronary Intervention in patients with Heparin-Induced Thrombocytopenia (AT BAT, First Inning)
  ClinicalTrials.gov Identifier: NCT00043940 - Completed
  Heparin-Induced Thrombocytopenia; Thrombosis
  
• Safety and efficacy of an investigational drug in the prevention of thrombocytopenia in recurrent or refractory non-Burkitt's, non-Hodgkin's lymphoma (NHL) or Hodgkin's disease receiving DHAP (Dexamethasone, high-dose Cytarabine and Cisplatin) chemotherap
  ClinicalTrials.gov Identifier: NCT00039910 - Completed
  Non-Hodgkin Lymphoma; Hodgkin Disease; Thrombocytopenia
  
• Evaluating the Safety and Efficacy of AMG 531 in Thrombocytopenic Subjects with Immune Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00111475 - Completed
  Idiopathic Thrombocytopenic Purpura
  
• Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
  ClinicalTrials.gov Identifier: NCT00010335 - Recruiting
  Systemic Sclerosis; Systemic Lupus Erythematosus; Dermatomyositis; Juvenile Rheumatoid Arthritis; Autoimmune Diseases
  
• Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00467571 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura; Helicobacter Pylori Infection
  
• Strategies for Transfusion of Platelets (SToP)
  ClinicalTrials.gov Identifier: NCT00420914 - Recruiting
  Thrombocytopenia
  
• Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects with Immune Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00117143 - Completed
  Purpura, Thrombocytopenic
  
• Autoimmune Hepatitis Study
  ClinicalTrials.gov Identifier: NCT00286663 - Recruiting
  Hepatitis, Autoimmune
  
• Steroid Therapy in Autoimmune Premature Ovarian Failure
  ClinicalTrials.gov Identifier: NCT00001306 - Recruiting
  Autoimmune Disease; Infertility; Premature Ovarian Failure
  
• Rituximab as Second Line Treatment for ITP
  ClinicalTrials.gov Identifier: NCT00344149 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• (Eltrombopag Extended Dosing Study)in Adults
  ClinicalTrials.gov Identifier: NCT00351468 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products
  ClinicalTrials.gov Identifier: NCT00263809 - Recruiting
  Thrombocytopenia
  
• Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
  ClinicalTrials.gov Identifier: NCT00001350 - Recruiting
  Autoimmune Disease; Lymphatic Disease; Lymphoproliferative Disorder; Canale-Smith Syndrome
  
• Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days
  ClinicalTrials.gov Identifier: NCT00261924 - Recruiting
  Thrombocytopenia
  
• Registry for Vascular Anomalies Associated With Coagulopathy
  ClinicalTrials.gov Identifier: NCT00576888 - Recruiting
  Multifocal Lymphangioendotheliomatosis With Thrombocytopenia; Cutaneovisceral Angiomatosis With Thrombocytpopenia
  
• Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
  ClinicalTrials.gov Identifier: NCT00039858 - Completed
  Thrombocytopenia; Thrombosis
  
• Interleukin 11, Thrombocytopenia, CML, Imatinib in CML Patients
  ClinicalTrials.gov Identifier: NCT00493181 - Active, not recruiting
  Leukemia; Chronic Myelogenous Leukemia; CML
  
• MMF Versus Intravenous CTX Pulses in the Treatment of Adult Severe Henoch-Schonlein Purpura Nephritis
  ClinicalTrials.gov Identifier: NCT00301613 - Completed
  Henoch-Schoenlein Purpura; Nephritis
  
• Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00486421 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10
  ClinicalTrials.gov Identifier: NCT00168038 - Completed
  Immune Thrombocytopenic Purpura
  
• Study and Treatment of Inflammatory Muscle Diseases
  ClinicalTrials.gov Identifier: NCT00001265 - Recruiting
  Autoimmune Disease; Dermatomyositis; Inclusion Body Myositis; Myositis; Polymyositis
  
• Differential Gene Expression of Liver Tissue and Blood from Individuals with Chronic Viral Hepatitis
  ClinicalTrials.gov Identifier: NCT00160940 - Recruiting
  Hepatitis C; Hepatitis B; Autoimmune Hepatitis; Liver Cirrhosis, Biliary; Cholangitis, Sclerosing
  
• Ig NextGen 10% in ITP Patients
  ClinicalTrials.gov Identifier: NCT00362349 - Recruiting
  Idiopathic Thrombocytopenic Purpura (ITP)
  
• Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00471653 - Recruiting
  Brain and Central Nervous System Tumors; Thrombocytopenia
  
• Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
  ClinicalTrials.gov Identifier: NCT00412464 - Recruiting
  Thrombosis; Heparin-Induced Thrombocytopenia
  
• A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients with HIV-Associated Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00002250 - Completed
  Immune thrombocytopenic purpura ( ITP ); HIV Infections
  
• High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP
  ClinicalTrials.gov Identifier: NCT00451594 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Determination of Safe Dose of AMG 531 in Subjects With MDS
  ClinicalTrials.gov Identifier: NCT00303472 - Recruiting
  MDS; Myelodysplastic Syndromes; Refractory Cytopenias; Thrombocytopenia
  
• Eltrombopag to Initiate and Maintain Interferon Antiviral Treatment to Subjects With Hepatitis C Related Liver Disease
  ClinicalTrials.gov Identifier: NCT00516321 - Recruiting
  Thrombocytopenia; Hepatitis C
  
• A Randomized Study of IVIG Vs. IVIG With High Dose Methylprednisolone in Childhood ITP.
  ClinicalTrials.gov Identifier: NCT00376077 - Recruiting
  Immune Thrombocytopenic Purpura
  
• Dose Evaluation Study Of Oral Eltrombopag In Patients With Sarcoma Receiving The ADRIAMYCIN And Ifosfamide Regimen
  ClinicalTrials.gov Identifier: NCT00358540 - Recruiting
  Sarcoma; Thrombocytopenia; Thrombopoiesis
  
• A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid
  ClinicalTrials.gov Identifier: NCT00418665 - Recruiting
  Myelodysplastic Syndromes; Thrombocytopenia
  
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With ITP
  ClinicalTrials.gov Identifier: NCT00441090 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  
• Rituximab, Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Sodium Thiosulfate and Cytarabine in Treating Patients With Refractory or Recurrent Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00074165 - Recruiting
  Drug Toxicity; Thrombocytopenia; intraocular lymphoma; primary central nervous system lymphoma
  
• Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study
  ClinicalTrials.gov Identifier: NCT00341198 - Completed
  Autoimmune Disease
  
• Determination of Safe and Effective Dose of AMG 531 in Subjects With MDS Receiving Hypomethylating Agents
  ClinicalTrials.gov Identifier: NCT00321711 - Recruiting
  MDS; Myelodysplastic Syndromes; Refractory Cytopenias; Thrombocytopenia
  
• Efficacy and Safety of IVIG-L in ITP Patients
  ClinicalTrials.gov Identifier: NCT00151840 - Completed
  Purpura, Thrombocytopenic, Idiopathic